
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>COVID-19 - Infectious Diseases - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "d88c399d-ac91-44cd-a31a-0e71b2f9c3c3";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v58251886";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "a66c917c-80cb-4010-bc48-0a5fb7bf4804",
 VasontId : "v56817076"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "31b9cca6-b744-4d01-a4c5-6642dd6c8f29",
 VasontId : "v878841"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = 'b8c1bf54-41c9-406f-b28c-c2c59a7b5238';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 COVID-19
 </h1>
 <h2 class="topic__section topic__header__headermodify--subtitle">(Coronavirus Disease 2019; COVID)</h2>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/tesini-brenda.html">Brenda L. Tesini</a></strong>
 <p class="topic__authors--description">, MD, University of Rochester School of Medicine and Dentistry</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Nov 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v58251914" class="topicmenu_mobile__paragraph">Transmission</a>
 </li>
 <li>
 <a href="#v58251947" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v58252018" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v58252051" class="topicmenu_mobile__paragraph">Treatment</a>
 </li>
 <li>
 <a href="#v70338676" class="topicmenu_mobile__paragraph">Post–COVID-19 Infection</a>
 </li>
 <li>
 <a href="#v58252121" class="topicmenu_mobile__paragraph">Prevention</a>
 </li>
 <li>
 <a href="#v58252229" class="topicmenu_mobile__paragraph">More Information</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Biodigitals'); }, keypress: function() { $data.activateGroup('Biodigitals'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 3D Models (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--biodigital" data-group-name="biodigital" title="SARS-CoV-2">
 <div class="">
 <img class="--image" src="./~/media/manual/professional/images/b/i/o/biodigital-sarscov2-pv-sized.jpg?thn=0&sc_lang=en" width="242" height="161" loading="lazy">
 </div>
 <span class="hero__description">
 SARS-CoV-2
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"https://human.biodigital.com/viewer/?be=3Or1\u0026ui-info=true\u0026ui-search=true\u0026ui-reset=true\u0026ui-fullscreen=true\u0026ui-nav=true\u0026ui-tools=true\u0026ui-help=true\u0026ui-chapter-list=false\u0026ui-label-list=true\u0026ui-anatomy-descriptions=false\u0026disable-scroll=false\u0026uaid=5Itjh","ItemId":"96ef9c3c-c9e3-4feb-be33-26298b53ba73","Title":"SARS-CoV-2","ShareUrlTitle":"sars-cov-2","Description":"","ImageUrl":"./~/media/manual/professional/images/b/i/o/biodigital-sarscov2-pv-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/i/o/biodigital-sarscov2-pv-sized.jpg?thn=0\u0026sc_lang=en","MediaType":"biodigital","MediaNameTranslated":"3D%20Model","UniqueId":"v58251843","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"242","ImageHeight":"161","Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"SARS-CoV-2","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%203D%20Model","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Calculators (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Images (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Tables (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v58251908" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory failure and death. COVID-19 can involve multiple organ systems (eg, cardiac, renal, neurologic, coagulation). Prevention is by vaccination and infection control precautions (eg, face masks, handwashing, social distancing, isolation of infected individuals). Diagnosis is by antigen or PCR (polymerase chain reaction) testing of upper or lower respiratory secretions. Treatment is with supportive care, antiviral drugs, or corticosteroids.</div></p></div> <div class="inlinemedia-component " data-ko-rebind="v58251843" data-bind="component: {name: 'inlinemedia-biodigital', params: $data}" data-inline-model='{"IframeSrc":"https://human.biodigital.com/viewer/?be=3Or1\u0026ui-info=true\u0026ui-search=true\u0026ui-reset=true\u0026ui-fullscreen=true\u0026ui-nav=true\u0026ui-tools=true\u0026ui-help=true\u0026ui-chapter-list=false\u0026ui-label-list=true\u0026ui-anatomy-descriptions=false\u0026disable-scroll=false\u0026uaid=5Itjh","ItemId":"96ef9c3c-c9e3-4feb-be33-26298b53ba73","Title":"SARS-CoV-2","ShareUrlTitle":"sars-cov-2","Description":"","ImageUrl":"./~/media/manual/professional/images/b/i/o/biodigital-sarscov2-pv-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/i/o/biodigital-sarscov2-pv-sized.jpg?thn=0\u0026sc_lang=en","MediaType":"biodigital","MediaNameTranslated":"3D Model","UniqueId":"v58251843","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"242","ImageHeight":"161","Target":null,"Alt":null}'> </div><span id="v58251911" class="anchor"></span><div class="para"> <p>COVID-19 was first reported in late 2019 in Wuhan, China and declared a pandemic by the World Health Organization (WHO) in March 2020. It is caused by SARS-CoV-2, a coronavirus discovered in 2019. SARS-CoV-2 infection causes a spectrum of severity of disease, from asymptomatic to acute <a href="./{A3683904-07B7-4347-AE9E-4A20EA415D58}.html" data-toggle="tooltip" title="Overview of Respiratory Failure" data-id="009ec45a-4462-4fa6-adeb-1f76228f0402" data-itemid="a3683904-07b7-4347-ae9e-4a20ea415d58">respiratory failure</a><span id="009ec45a-4462-4fa6-adeb-1f76228f0402" class="d-none xref"> <span class="tooltip-container"> <a href="./{A3683904-07B7-4347-AE9E-4A20EA415D58}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Respiratory Failure </span> Acute respiratory failure is a life-threatening impairment of oxygenation, carbon dioxide elimination, or both. Respiratory failure may occur because of impaired gas exchange, decreased ventilation... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and death. Risk factors for severe disease include older age, immunocompromise, comorbidities (eg, diabetes, chronic kidney disease), and pregnancy. <a href="./{15803A40-86F8-457C-9891-8DE8532EDB52}.html" data-toggle="tooltip" title="COVID-19 Vaccine" data-id="840b05f2-d650-4dfd-8576-7a6257c3f754" data-itemid="15803a40-86f8-457c-9891-8de8532edb52">Vaccines</a><span id="840b05f2-d650-4dfd-8576-7a6257c3f754" class="d-none xref"> <span class="tooltip-container"> <a href="./{15803A40-86F8-457C-9891-8DE8532EDB52}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> COVID-19 Vaccine </span> COVID-19 vaccines provide protection against COVID-19, the disease caused by infection with the SARS-CoV-2 virus. Vaccination is the most effective strategy to prevent severe illness and death... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> have shown to be somewhat effective in preventing transmission and very effective in preventing severe disease and mortality. </p></div><span id="v70338499" class="anchor"></span><div class="para"> <p>For current information on the number of cases and fatalities, see the <a rel="nofollow" target="_blank" href="https://covid.cdc.gov/covid-data-tracker/#datatracker-home">Centers for Disease Control and Prevention (CDC): COVID Data Tracker</a> and the <a rel="nofollow" target="_blank" href="https://covid19.who.int/">WHO Coronavirus (COVID-19) Dashboard</a>.</p></div> <section id="v58251914" class="topic__section FHead"> <h2 id="" class="topic__header--section" data-originaltitle="Transmission"> <span id="v58251915" class="anchor"></span> Transmission of COVID-19 </h2> <div class="topic__content"> <span id="v58251916" class="anchor"></span><div class="para"> <p>The SARS-CoV-2 virus spreads by close person-to-person contact, mainly via respiratory droplets produced when an infected person coughs, sneezes, sings, exercises, or talks. The spread occurs through large respiratory droplets that can travel short distances and land directly on mucosal surfaces or through small respiratory particle aerosols that can linger in air for several hours and travel longer distances (> 6 feet) before being inhaled. Spread of the virus could also occur via contact with surfaces contaminated (fomites) by respiratory secretions, if a person touches a contaminated surface and then touches a mucous membrane on the face (eyes, nose, mouth). </p></div><span id="v58251917" class="anchor"></span><div class="para"> <p>The SARS-CoV-2 virus spreads easily between people. The risk of transmission is directly related to the amount of virus to which a person is exposed. In general, the closer and longer the interaction with an infected person, the higher the risk of virus spread. Both asymptomatic and symptomatic patients can transmit the virus, making it difficult to control spread. A symptomatic person is most contagious for the several days before and after the onset of symptoms, at which time the viral load in respiratory secretions is greatest. </p></div><span id="v64013767" class="anchor"></span><div class="para"> <p>Factors such as distance from an infected person, the number of infected people in the room, the duration of time spent with infected people, the size of the air space, aerosol-generating activity (eg, singing, shouting, or exercising), ventilation in the location, and the direction and speed of airflow can contribute to this risk. </p></div><span id="v70338502" class="anchor"></span><div class="para"> <p>Genetic variants of the SARS-CoV-2 virus emerge as it evolves. Variants with the potential for increased transmissibility, more severe disease, diagnostic detection failures, or reduced response to available treatments and/or vaccines are tracked as Variants of Concern and are commonly referred to by their WHO-designated Greek alphabet label or their Pango lineage number. A genetic mutation that confers a fitness advantage, namely increased transmissibility, can rapidly replace previously circulating variants. The progression of dominant variants in the United States and much of the world includes Alpha, Beta, Delta, and Omicron. The Omicron variant has predominated worldwide since March 2022, with newer and more transmissible Omicron subvariants (eg, BA.4 and BA.5) replacing the original Omicron (B.1.1.529). See also <a rel="nofollow" target="_blank" href="https://covid.cdc.gov/covid-data-tracker/#variants-genomic-surveillance">CDC: Variants & Genomic Surveillance</a>.</p></div><span id="v58251920" class="anchor"></span><div class="para"> <p>Situations with high risk of transmission include congregate living facilities (eg, elder care or other long-term care facilities, residential schools, prisons, ships) as well as crowded, poorly ventilated environments, such as indoor religious services, gyms, bars, nightclubs, indoor restaurants, and meat-packing facilities. Such situations have a high population density in which maintaining distance and ventilation precautions is difficult. The residents of elder care facilities are also at high risk of severe disease because of age and underlying medical disorders. Large indoor events or private gatherings such as meetings or weddings have also been associated with high transmission rates. These so-called super-spreader events or situations are probably due to a combination of biological, environmental, and behavioral factors.</p></div><span id="v70338504" class="anchor"></span><div class="para"> <p>Social determinants of health (conditions in the places where people are born, live, learn, work, and play) impact a wide range of health risks and outcomes, such as exposure to SARS-CoV-2 infection, severe COVID-19, and death, as well as access to testing, vaccination, and treatment. In the United States, COVID-19 case, hospitalization, and death rates are higher in some racial and ethnic minority groups, including among people who are Black, Hispanic or Latino, American Indian, and Alaska Native. </p></div><span id="v70338506" class="anchor"></span><div class="para"> <p>For people infected with COVID-19, isolation and precaution measures are recommended in an attempt to limit the spread of SARS-CoV-2 infection. (See also <a rel="nofollow" target="_blank" href="https://www.cdc.gov/coronavirus/2019-ncov/your-health/isolation.html">CDC: Isolation and Precautions for People with COVID-19</a>.) For people exposed to COVID-19, precautions are recommended to help reduce the risk of spreading the virus. (See also <a rel="nofollow" target="_blank" href="https://www.cdc.gov/coronavirus/2019-ncov/your-health/if-you-were-exposed.html">CDC: What to Do If You Were Exposed to COVID-19</a>.)</p></div> </div> </section> <section id="v58251947" class="topic__section FHead" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <h2 id="" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v58251948" class="anchor"></span> Symptoms and Signs of COVID-19 </h2> <div class="topic__content"> <span id="v58251949" class="anchor"></span><div class="para"> <p>The severity and constellation of symptoms vary in people with COVID-19. Some have few to no symptoms, and some become severely ill and die. Symptoms may include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v58251952" class="anchor"></span><div class="para"> <p>Fever</p></div></li><li class="topic__listitem"><span id="v58251954" class="anchor"></span><div class="para"> <p>Cough</p></div></li><li class="topic__listitem"><span id="v58251966" class="anchor"></span><div class="para"> <p>Sore throat</p></div></li><li class="topic__listitem"><span id="v58251970" class="anchor"></span><div class="para"> <p>Congestion or runny nose</p></div></li><li class="topic__listitem"><span id="v58251956" class="anchor"></span><div class="para"> <p>Shortness of breath or difficulty breathing</p></div></li><li class="topic__listitem"><span id="v58251958" class="anchor"></span><div class="para"> <p>Chills or repeated shaking with chills</p></div></li><li class="topic__listitem"><span id="v62110414" class="anchor"></span><div class="para"> <p>New loss of smell or taste</p></div></li><li class="topic__listitem"><span id="v58251960" class="anchor"></span><div class="para"> <p>Fatigue</p></div></li><li class="topic__listitem"><span id="v58251962" class="anchor"></span><div class="para"> <p>Muscle pain</p></div></li><li class="topic__listitem"><span id="v58251964" class="anchor"></span><div class="para"> <p>Headache</p></div></li><li class="topic__listitem"><span id="v58251972" class="anchor"></span><div class="para"> <p>Nausea or vomiting </p></div></li><li class="topic__listitem"><span id="v58251974" class="anchor"></span><div class="para"> <p>Diarrhea</p></div></li></ul></div><span id="v58251975" class="anchor"></span><div class="para"> <p>The incubation period (ie, time from exposure to symptom onset) ranges from 2 to 10 days, with a median estimated to be only 2 to 4 days for the Omicron variant (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010" data-toggle="tooltip" title="Symptoms and signs references" data-id="46e22543-2327-46c0-820d-527e669cc84e" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">1</a><span id="46e22543-2327-46c0-820d-527e669cc84e" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010"> <span class="tooltip-content"> <span class="tooltip-heading"> Symptoms and signs references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Many infected people have no symptoms or mild disease; the likelihood of this varies depending on the SARS-CoV-2 variant and person's risk for severe disease, including COVID immunization status. </p></div><span id="v70338509" class="anchor"></span><div class="para"> <p>Severe disease is characterized by dyspnea, hypoxia, and extensive lung involvement on imaging. This can progress to <a href="./{A3683904-07B7-4347-AE9E-4A20EA415D58}.html" data-toggle="tooltip" title="Overview of Respiratory Failure" data-id="f0903924-f939-45be-bb28-2f09e50ebec3" data-itemid="a3683904-07b7-4347-ae9e-4a20ea415d58">respiratory failure</a><span id="f0903924-f939-45be-bb28-2f09e50ebec3" class="d-none xref"> <span class="tooltip-container"> <a href="./{A3683904-07B7-4347-AE9E-4A20EA415D58}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Respiratory Failure </span> Acute respiratory failure is a life-threatening impairment of oxygenation, carbon dioxide elimination, or both. Respiratory failure may occur because of impaired gas exchange, decreased ventilation... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> requiring mechanical ventilation, shock, multiorgan failure, and death.</p></div> <section id="v70338511" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v70338512" class="anchor"></span> Risk factors for severe disease </h3> <div class="topic__content"> <span id="v70338513" class="anchor"></span><div class="para"> <p>The risk of serious disease and death in COVID-19 cases increases in people over age 65, in people who smoke or previously smoked, and in people with other serious medical disorders, such as </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v70338516" class="anchor"></span><div class="para"> <p>Cancer</p></div></li><li class="topic__listitem"><span id="v70338518" class="anchor"></span><div class="para"> <p>Chronic heart, lung, kidney, or liver disease</p></div></li><li class="topic__listitem"><span id="v70338520" class="anchor"></span><div class="para"> <p>Diabetes</p></div></li><li class="topic__listitem"><span id="v70338522" class="anchor"></span><div class="para"> <p>Stroke or cerebrovascular disease</p></div></li><li class="topic__listitem"><span id="v70338524" class="anchor"></span><div class="para"> <p>Immunocompromising conditions</p></div></li><li class="topic__listitem"><span id="v70338526" class="anchor"></span><div class="para"> <p>HIV infection</p></div></li><li class="topic__listitem"><span id="v70338528" class="anchor"></span><div class="para"> <p>Tuberculosis</p></div></li><li class="topic__listitem"><span id="v70338530" class="anchor"></span><div class="para"> <p>Sickle cell disease</p></div></li><li class="topic__listitem"><span id="v70338532" class="anchor"></span><div class="para"> <p>Thalassemia</p></div></li><li class="topic__listitem"><span id="v70338534" class="anchor"></span><div class="para"> <p>Dementia</p></div></li><li class="topic__listitem"><span id="v70338536" class="anchor"></span><div class="para"> <p>Obesity</p></div></li><li class="topic__listitem"><span id="v70338538" class="anchor"></span><div class="para"> <p>Pregnancy (up to 42 days after pregnancy)</p></div></li><li class="topic__listitem"><span id="v70338540" class="anchor"></span><div class="para"> <p>Some types of disabilities</p></div></li><li class="topic__listitem"><span id="v70338542" class="anchor"></span><div class="para"> <p>Substance use disorders</p></div></li><li class="topic__listitem"><span id="v70338544" class="anchor"></span><div class="para"> <p>Physical inactivity</p></div></li><li class="topic__listitem"><span id="v70338546" class="anchor"></span><div class="para"> <p>Some mental health disorders such as depression and schizophrenia </p></div></li></ul></div><span id="v70338547" class="anchor"></span><div class="para"> <p>(Also see <a rel="nofollow" target="_blank" href="https://www.cdc.gov/coronavirus/2019-ncov/your-health/understanding-risk.html">CDC: COVID-19 Understanding Risk</a>.)</p></div><span id="v70338549" class="anchor"></span><div class="para"> <p> <a href="./{15803A40-86F8-457C-9891-8DE8532EDB52}.html" data-toggle="tooltip" title="COVID-19 Vaccine" data-id="27c6ebbc-4260-4754-9a19-1cd11071c84f" data-itemid="15803a40-86f8-457c-9891-8de8532edb52">Vaccination</a><span id="27c6ebbc-4260-4754-9a19-1cd11071c84f" class="d-none xref"> <span class="tooltip-container"> <a href="./{15803A40-86F8-457C-9891-8DE8532EDB52}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> COVID-19 Vaccine </span> COVID-19 vaccines provide protection against COVID-19, the disease caused by infection with the SARS-CoV-2 virus. Vaccination is the most effective strategy to prevent severe illness and death... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> dramatically lowers the risk of severe illness for all age groups—lower vaccination rates in younger age groups has shifted the age demographic of hospitalized patients (see <a rel="nofollow" target="_blank" href="https://covid.cdc.gov/covid-data-tracker/#datatracker-home">CDC: COVID Data Tracker</a>). </p></div> </div> </section> <section id="v70338552" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v70338553" class="anchor"></span> Complications </h3> <div class="topic__content"> <span id="v70338554" class="anchor"></span><div class="para"> <p>In addition to respiratory disease that can progress to acute respiratory distress syndrome (<a href="./{E5694A16-9F21-42DA-9472-818020AF6C25}.html" data-toggle="tooltip" title="Acute Hypoxemic Respiratory Failure (AHRF, ARDS)" data-id="81367ab6-a723-4468-aa13-f96bb92114fa" data-itemid="e5694a16-9f21-42da-9472-818020af6c25">ARDS</a><span id="81367ab6-a723-4468-aa13-f96bb92114fa" class="d-none xref"> <span class="tooltip-container"> <a href="./{E5694A16-9F21-42DA-9472-818020AF6C25}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Hypoxemic Respiratory Failure (AHRF, ARDS) </span> Acute hypoxemic respiratory failure is defined as severe hypoxemia (PaO2 (See also Overview of Mechanical Ventilation.) Airspace filling in acute hypoxemic respiratory failure (AHRF) may result... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/u/l/pulmonary_edema_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Hypoxemic Respiratory Failure (AHRF, ARDS)" loading="lazy"> </span> </a> </span> </span>) and death, other serious complications include the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v70338558" class="anchor"></span><div class="para"> <p>Heart disorders including <a href="./{92771FD9-053D-4C64-BCCD-52F7C8C85D58}.html" data-toggle="tooltip" title="Overview of Arrhythmias" data-id="8c4b0cd1-89bb-4c70-ac32-27abef601d71" data-itemid="92771fd9-053d-4c64-bccd-52f7c8c85d58">arrhythmias</a><span id="8c4b0cd1-89bb-4c70-ac32-27abef601d71" class="d-none xref"> <span class="tooltip-container"> <a href="./{92771FD9-053D-4C64-BCCD-52F7C8C85D58}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Arrhythmias </span> The normal heart beats in a regular, coordinated way because electrical impulses generated and spread by myocytes with unique electrical properties trigger a sequence of organized myocardial... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/1/2/612-cardiac-action-potential-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Arrhythmias" loading="lazy"> </span> </a> </span> </span>, <a href="./{03E6F4AB-4402-4C9B-BE9C-D8E59DFDDF1F}.html" data-toggle="tooltip" title="Overview of Cardiomyopathies" data-id="3e1cf7c8-83de-4526-9410-748e41e57c5b" data-itemid="03e6f4ab-4402-4c9b-be9c-d8e59dfddf1f">cardiomyopathy</a><span id="3e1cf7c8-83de-4526-9410-748e41e57c5b" class="d-none xref"> <span class="tooltip-container"> <a href="./{03E6F4AB-4402-4C9B-BE9C-D8E59DFDDF1F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Cardiomyopathies </span> A cardiomyopathy is a primary disorder of the heart muscle. It is distinct from structural cardiac disorders such as coronary artery disease, valvular disorders, and congenital heart disorders... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, and acute cardiac injury </p></div></li><li class="topic__listitem"><span id="v70338562" class="anchor"></span><div class="para"> <p>Coagulation disorders including thromboembolism and <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html" data-toggle="tooltip" title="Pulmonary Embolism (PE)" data-id="533ac0c3-5bb5-41e8-b36a-3a3b37feb8fb" data-itemid="04bdb331-74e7-4552-b984-0e863fc6c2cd">pulmonary emboli</a><span id="533ac0c3-5bb5-41e8-b36a-3a3b37feb8fb" class="d-none xref"> <span class="tooltip-container"> <a href="./{04BDB331-74E7-4552-B984-0E863FC6C2CD}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Pulmonary Embolism (PE) </span> Pulmonary embolism (PE) is the occlusion of pulmonary arteries by thrombi that originate elsewhere, typically in the large veins of the legs or pelvis. Risk factors for pulmonary embolism are... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/h/e/chest-cta-joined-tapson-crop.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pulmonary Embolism (PE)" loading="lazy"> </span> </a> </span> </span>, <a href="./{18F67047-6499-41D9-B1CC-0C4290E7C571}.html" data-toggle="tooltip" title="Disseminated Intravascular Coagulation (DIC)" data-id="5e0e5a47-772a-4d1c-8e31-f34d08dfba57" data-itemid="18f67047-6499-41d9-b1cc-0c4290e7c571">disseminated intravascular coagulation (DIC)</a><span id="5e0e5a47-772a-4d1c-8e31-f34d08dfba57" class="d-none xref"> <span class="tooltip-container"> <a href="./{18F67047-6499-41D9-B1CC-0C4290E7C571}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Disseminated Intravascular Coagulation (DIC) </span> Disseminated intravascular coagulation (DIC) involves abnormal, excessive generation of thrombin and fibrin in the circulating blood. During the process, increased platelet aggregation and coagulation... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, hemorrhage, and arterial clot formation</p></div></li><li class="topic__listitem"><span id="v70338566" class="anchor"></span><div class="para"> <p> <a href="./{0B9D3DEF-A946-457B-ACE9-670F2DA6722E}.html" data-toggle="tooltip" title="Guillain-Barré Syndrome (GBS)" data-id="8f50ed38-a9d6-46e0-a545-cc7c4fa97fee" data-itemid="0b9d3def-a946-457b-ace9-670f2da6722e">Guillain-Barré syndrome</a><span id="8f50ed38-a9d6-46e0-a545-cc7c4fa97fee" class="d-none xref"> <span class="tooltip-container"> <a href="./{0B9D3DEF-A946-457B-ACE9-670F2DA6722E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Guillain-Barré Syndrome (GBS) </span> Guillain-Barré syndrome is an acute, usually rapidly progressive but self-limited, inflammatory polyneuropathy characterized by muscular weakness and mild distal sensory loss. Cause is thought... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (rare)</p></div></li><li class="topic__listitem"><span id="v70338569" class="anchor"></span><div class="para"> <p> <a href="./{782B9C7A-5E19-4F74-8DFF-B01F4B34D529}.html" data-toggle="tooltip" title="Sepsis and Septic Shock" data-id="d3e6751d-0412-405b-adf3-064133157b3a" data-itemid="782b9c7a-5e19-4f74-8dff-b01f4b34d529">Sepsis</a><span id="d3e6751d-0412-405b-adf3-064133157b3a" class="d-none xref"> <span class="tooltip-container"> <a href="./{782B9C7A-5E19-4F74-8DFF-B01F4B34D529}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Sepsis and Septic Shock </span> Sepsis is a clinical syndrome of life-threatening organ dysfunction caused by a dysregulated response to infection. In septic shock, there is critical reduction in tissue perfusion; acute failure... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{325CC6A6-C2A7-4B95-A6DC-7BB5B819D97F}.html" data-toggle="tooltip" title="Shock" data-id="3dee1aa9-dcb7-4620-a8ed-7fa9ae439edc" data-itemid="325cc6a6-c2a7-4b95-a6dc-7bb5b819d97f">shock</a><span id="3dee1aa9-dcb7-4620-a8ed-7fa9ae439edc" class="d-none xref"> <span class="tooltip-container"> <a href="./{325CC6A6-C2A7-4B95-A6DC-7BB5B819D97F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Shock </span> Shock is a state of organ hypoperfusion with resultant cellular dysfunction and death. Mechanisms may involve decreased circulating volume, decreased cardiac output, and vasodilation, sometimes... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, and multiorgan failure</p></div></li></ul></div><span id="v70338572" class="anchor"></span><div class="para"> <p>A postinfectious inflammatory syndrome termed <b>multisystem inflammatory syndrome in children (MIS-C) </b>has been observed as a rare complication of SARS-CoV-2 infection. It has features similar to <a href="./{498A2D50-CCB8-427E-896B-5C8322590A89}.html" data-toggle="tooltip" title="Kawasaki Disease" data-id="fb4707df-41e6-4d75-a233-122fd89cb7ba" data-itemid="498a2d50-ccb8-427e-896b-5c8322590a89">Kawasaki disease</a><span id="fb4707df-41e6-4d75-a233-122fd89cb7ba" class="d-none xref"> <span class="tooltip-container"> <a href="./{498A2D50-CCB8-427E-896B-5C8322590A89}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Kawasaki Disease </span> Kawasaki disease is a vasculitis, sometimes involving the coronary arteries, that tends to occur in infants and children between the ages of 1 year and 8 years. It is characterized by prolonged... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/1/8/418-kawasaki-disease-exanthem-slide-2-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Kawasaki Disease" loading="lazy"> </span> </a> </span> </span> or <a href="./{6F04B261-C6A5-4F2A-B408-590819D9C9B3}.html" data-toggle="tooltip" title="Toxic Shock Syndrome (TSS)" data-id="689827e7-875f-4e9d-8f81-9c46801cec6a" data-itemid="6f04b261-c6a5-4f2a-b408-590819d9c9b3">toxic shock syndrome</a><span id="689827e7-875f-4e9d-8f81-9c46801cec6a" class="d-none xref"> <span class="tooltip-container"> <a href="./{6F04B261-C6A5-4F2A-B408-590819D9C9B3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Toxic Shock Syndrome (TSS) </span> Toxic shock syndrome is caused by staphylococcal or streptococcal exotoxins. Manifestations include high fever, hypotension, diffuse erythematous rash, and multiple organ dysfunction, which... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/t/a/staphylococcal_scalded_skin_c_orig_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Toxic Shock Syndrome (TSS)" loading="lazy"> </span> </a> </span> </span>. Children with MIS-C most commonly present with fever, tachycardia, signs of systemic inflammation, and multisystem involvement (eg, cardiac, gastrointestinal, renal) at 2 to 6 months following a generally mild or even asymptomatic SARS-CoV-2 infection. Cases meeting the following criteria should be reported to local, state, or territorial health departments as suspected MIS-C: individuals < 21 years old with fever> 24 hours, laboratory evidence of inflammation, signs of severe multisystem (≥ 2 organs) involvement requiring hospitalization, and laboratory or epidemiologic association with recent SARS-CoV-2 infection (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010" data-toggle="tooltip" title="Symptoms and signs references" data-id="317d5ec7-b2a2-453e-8b4c-2b0020fbae79" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">2</a><span id="317d5ec7-b2a2-453e-8b4c-2b0020fbae79" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010"> <span class="tooltip-content"> <span class="tooltip-heading"> Symptoms and signs references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Vaccination appears to be highly protective against the development of MIS-C (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010" data-toggle="tooltip" title="Symptoms and signs references" data-id="9c3f13e4-bef0-4c02-8c4e-749db27c9aa5" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">2</a><span id="9c3f13e4-bef0-4c02-8c4e-749db27c9aa5" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010"> <span class="tooltip-content"> <span class="tooltip-heading"> Symptoms and signs references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). A similar multisystem inflammatory syndrome in young and middle-aged adults (MIS-A) also has been reported (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010" data-toggle="tooltip" title="Symptoms and signs references" data-id="f751d2ca-31db-4145-8919-37788d8df6ee" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">3</a><span id="f751d2ca-31db-4145-8919-37788d8df6ee" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010"> <span class="tooltip-content"> <span class="tooltip-heading"> Symptoms and signs references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div> </div> </section> <section id="v58252003" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v58252004" class="anchor"></span> Symptom resolution </h3> <div class="topic__content"> <span id="v58252005" class="anchor"></span><div class="para"> <p>In most patients, symptoms resolve within about a week. However, some patients begin with mild symptoms, then clinically deteriorate after a week, progressing to severe disease, including <a href="./{E5694A16-9F21-42DA-9472-818020AF6C25}.html" data-toggle="tooltip" title="Acute Hypoxemic Respiratory Failure (AHRF, ARDS)" data-id="27ebeca4-9f55-4da7-b92f-57c094dac7a5" data-itemid="e5694a16-9f21-42da-9472-818020af6c25">ARDS</a><span id="27ebeca4-9f55-4da7-b92f-57c094dac7a5" class="d-none xref"> <span class="tooltip-container"> <a href="./{E5694A16-9F21-42DA-9472-818020AF6C25}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Hypoxemic Respiratory Failure (AHRF, ARDS) </span> Acute hypoxemic respiratory failure is defined as severe hypoxemia (PaO2 (See also Overview of Mechanical Ventilation.) Airspace filling in acute hypoxemic respiratory failure (AHRF) may result... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/u/l/pulmonary_edema_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Hypoxemic Respiratory Failure (AHRF, ARDS)" loading="lazy"> </span> </a> </span> </span>. Prolonged illness appears to be more common in those with severe disease, but even patients with mild illness may have persistent symptoms, including dyspnea, cough, and malaise that last for weeks or even months. Viral PCR tests in patients may remain positive for at least 3 months regardless of symptoms. However, even patients with lingering symptoms are generally not considered infectious, as virus is rarely able to be cultured from the upper respiratory tract of patients after 10 days of illness. </p></div><span id="v62110420" class="anchor"></span><div class="para"> <p>COVID-19 may also be associated with long-term sequelae following acute illness (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010" data-toggle="tooltip" title="Symptoms and signs references" data-id="b2833ed9-4410-457b-89ba-8a52f41ccf48" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">4</a><span id="b2833ed9-4410-457b-89ba-8a52f41ccf48" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010"> <span class="tooltip-content"> <span class="tooltip-heading"> Symptoms and signs references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>), and symptoms from post–COVID-19 conditions can linger for months. This has been referred to by many names, including long COVID, long-haul COVID, and post-acute COVID-19 syndrome or condition, and is estimated to impact 25 to 50% of all patients in some United States surveys. Fatigue, weakness, pain, myalgias, dyspnea, and cognitive dysfunction are commonly reported and can be associated with a poorer quality of life (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010" data-toggle="tooltip" title="Symptoms and signs references" data-id="6fca2232-c132-4eb1-b7fd-2b0d6cf11ec0" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">5</a><span id="6fca2232-c132-4eb1-b7fd-2b0d6cf11ec0" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010"> <span class="tooltip-content"> <span class="tooltip-heading"> Symptoms and signs references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Risk factors for long-term sequelae may include more severe disease presentation, older age, female sex, and pre-existing lung disease. An international case definition has been established to aid in the diagnosis and further investigation of this condition (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010" data-toggle="tooltip" title="Symptoms and signs references" data-id="7514a4e6-d6e2-49de-99c6-7a19fad17fdb" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">6</a><span id="7514a4e6-d6e2-49de-99c6-7a19fad17fdb" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252010"> <span class="tooltip-content"> <span class="tooltip-heading"> Symptoms and signs references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div> </div> </section> <section id="v58252009" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"></span> <h3 id="" class="topic__header--subsection"> <span itemprop="name" id="v58252010" class="anchor"></span> Symptoms and signs references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v58252013" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736273/">Jansen L, Tegomoh B, Lange K, et al</a>: Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) variant cluster - Nebraska, November-December 2021. <i>MMWR Morb Mortal Wkly Rep</i> 70(5152):1782-2784, 2021. doi: 10.15585/mmwr.mm705152e3</p></div></li><li class="topic__listitem"><span id="v70338580" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214171/">Miller AD, Yousaf AR, Bornstein E, et al</a>: Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 Delta and Omicron variant circulation - United States, July 2021-January 2022. <i>Clin Infect Dis</i> Jun 10;ciac471, 2022. doi: 10.1093/cid/ciac471</p></div></li><li class="topic__listitem"><span id="v58252016" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.cdc.gov/mmwr/volumes/69/wr/mm6940e1.htm?s_cid=mm6940e1_w">Morris SB, Schwartz NG, Patel P, et al</a>: Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection — United Kingdom and United States, March–August 2020. <i>MMWR</i> 69:1450–1456, 2020. doi: 10.15585/mmwr.mm6940e1</p></div></li><li class="topic__listitem"><span id="v62110430" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893149/">Nalbandian A, Sehgal K, Gupta A, et al</a>: Post-acute COVID-19 syndrome. <i>Nat Med</i> 27(4):601-615, 2021. doi: 10.1038/s41591-021-01283-z</p></div></li><li class="topic__listitem"><span id="v86116737" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111447/">Han JH, Womack KN, Tenforde MW, et al</a>: Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. <i>Influenza Other Respir Viruses</i> 16(4):680-689, 2022. doi:10.1111/irv.12980</p></div></li><li class="topic__listitem"><span id="v62110434" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691845/">Soriano JB, Murthy S, Marshall JC, et al</a>: A clinical case definition of post-COVID-19 condition by a Delphi consensus. <i>Lancet Infect Dis</i> 22(4):e102-e107, 2022. doi: 10.1016/S1473-3099(21)00703-9</p></div></li></ul></div> </div> </section> </div> </section> <section id="v58252018" class="topic__section FHead"> <h2 id="" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v58252019" class="anchor"></span> Diagnosis of COVID-19 </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v58252022" class="anchor"></span><div class="para"> <p>Real-time reverse transcriptase–polymerase chain reaction (RT-PCR) or other nucleic acid amplification test (NAAT) of upper and lower respiratory secretions</p></div></li><li class="topic__listitem"><span id="v58252024" class="anchor"></span><div class="para"> <p>Antigen testing of upper respiratory secretions</p></div></li></ul></div><span id="v58252028" class="anchor"></span><div class="para"> <p>Diagnostic testing for COVID-19 is available through laboratories and public testing sites and can also be done at home. There are two main types of diagnostic COVID-19 tests: real-time reverse transcriptase–polymerase chain reaction (RT-PCR) (or other nucleic acid amplification test [NAAT]) and antigen tests. The choice of diagnostic test and its interpretation should be influenced by the likelihood of the person having COVID-19 based on the prevalence of SARS-CoV-2 in the population and the presence of COVID-19 symptoms, signs, or close contact with a known case of COVID-19. </p></div><span id="v70338582" class="anchor"></span><div class="para"> <p>RT-PCR has the highest analytical sensitivity and specificity and is the gold standard diagnostic test for COVID-19. Other NAAT platforms are generally slightly less sensitive than RT-PCR with equivalent specificity (see <a rel="nofollow" target="_blank" href="https://www.cdc.gov/coronavirus/2019-ncov/lab/naats.html">CDC: Nucleic Acid Amplification Tests</a>). Positive viral PCR tests, however, do not always indicate active infection. They can detect nonviable viral nucleic acid fragments and may remain positive for at least 3 months after initial diagnosis regardless of symptoms. </p></div><span id="v62110452" class="anchor"></span><div class="para"> <p>Point-of-care and home-based antigen testing can provide rapid results (see <a rel="nofollow" target="_blank" href="https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html">CDC: Considerations for SARS-CoV-2 Antigen Testing for Healthcare Providers Testing Individuals in the Community</a>). This can be an important measure to identify asymptomatic cases and interrupt SARS-CoV-2 transmission. Point-of-care or home-based antigen detection tests are less sensitive than NAATs, particularly at the onset of infection when viral load may be lower. The sensitivity of these tests compared to PCR tests vary by manufacturer and time course of infection, with ranges reported from 40 to 90% (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v70338592" data-toggle="tooltip" title="Diagnosis references" data-id="8f0f415d-35b2-4dd6-8a7e-d80a22787349" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">1-4</a><span id="8f0f415d-35b2-4dd6-8a7e-d80a22787349" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v70338592"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Therefore, it may be necessary to confirm some antigen test results (eg, a negative test in a person with symptoms) with an RT-PCR or other NAAT. Many antigen-detection test kits also recommend repeating the test serially over several days to increase the likelihood of detecting infection (see also <a rel="nofollow" target="_blank" href="https://www.fda.gov/medical-devices/safety-communications/home-covid-19-antigen-tests-take-steps-reduce-your-risk-false-negative-results-fda-safety">FDA: At-Home COVID-19 Antigen Tests-Take Steps to Reduce Your Risk of False Negative Results</a>). Some tests may not detect the Omicron variant or other emerging variants (see <a rel="nofollow" target="_blank" href="https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-viral-mutations-impact-covid-19-tests">FDA: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests</a>). Antigen tests are less likely to stay positive following resolution of infection since they only detect higher viral loads. However, other factors in addition to viral load can influence infectivity; therefore antigen test results do not necessarily correlate with infectiousness. </p></div><span id="v58252029" class="anchor"></span><div class="para"> <p>Acceptable specimens for COVID-19 diagnostic testing include nasopharyngeal, oropharyngeal, nasal mid-turbinate, anterior nares, and saliva. Refer to the accepting laboratory's collection instructions or test kit package insert instructions, because not all testing platforms and laboratories may be able to test all specimen types. These may be collected by a health care practitioner or self-collected, with the exception of nasopharyngeal specimens, which should only be collected by an appropriately trained and credentialed health care practitioner.</p></div><span id="v58252044" class="anchor"></span><div class="para"> <p>For nasopharyngeal and oropharyngeal specimens, use only synthetic fiber swabs with plastic or wire shafts. Do not use calcium alginate swabs or swabs with wooden shafts, as they may contain substances that inactivate some viruses and inhibit PCR testing. The swabs should be placed immediately into the transport tube provided. Maintain proper infection control when collecting specimens. </p></div><span id="v58252045" class="anchor"></span><div class="para"> <p>For biosafety reasons, local institutions and laboratories should not attempt to isolate the virus in cell culture. </p></div><span id="v58252047" class="anchor"></span><div class="para"> <p>Positive test results done in a laboratory or health care setting are reported to local and state health departments. Some local health departments also have mechanisms for reporting positive at home test results.</p></div><span id="v58252048" class="anchor"></span><div class="para"> <p>Serologic, or antibody, testing should not be used to diagnose acute COVID-19 illness, because antibodies most commonly become detectable only 1 to 3 weeks after symptom onset. Antibody tests are available that target the SARS-CoV-2 nucleocapsid antigen, spike antigen, and the receptor binding domain of the spike antigen. Tests that detect antibody to the nucleocapsid protein are recommended to evaluate for evidence of prior infection in vaccinated persons as that antigen is not included in the vaccine. Quantitative and semi-quantitative antibody assays are available, but there is currently no accepted correlate of immunity, and testing is not recommended to determine immune response to vaccination or infection (see <a rel="nofollow" target="_blank" href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing/antibody-tests-guidelines.html">CDC: Interim Guidelines for COVID-19 Antibody Testing</a>). </p></div> <section id="v70338586" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v70338587" class="anchor"></span> Evaluating symptomatic patients </h3> <div class="topic__content"> <span id="v70338588" class="anchor"></span><div class="para"> <p>Routine laboratory findings for those with more severe disease include lymphopenia as well as less specific findings of elevated aminotransaminase (ALT, AST) levels, elevated lactate dehydrogenase (LDH) levels, D-dimer, ferritin, and elevated inflammatory markers such as C-reactive protein.</p></div><span id="v70338589" class="anchor"></span><div class="para"> <p>Patients with dyspnea, hypoxia on home oximetry, or other concerning symptoms should be referred for in-person medical evaluation, including oxygen saturation measurement, and followed up with for signs of clinical deterioration.</p></div><span id="v70338590" class="anchor"></span><div class="para"> <p>Chest imaging findings can be normal with mild disease and increase with increasing severity of the illness. Typical findings are consistent with viral pneumonia and include ground-glass opacities and consolidation on either chest x-ray or chest CT. Chest imaging is not recommended as a routine screening tool for COVID-19.</p></div> </div> </section> <section id="v70338591" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v70338592" class="anchor"></span> Diagnosis references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v70338595" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820190/">Drain PK</a>: Rapid diagnostic testing for SARS-CoV-2. <i>N Engl J Med</i> 386(3):264-272, 2022. doi: 10.1056/NEJMcp2117115</p></div></li><li class="topic__listitem"><span id="v70338598" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083323/">Ford L, Lee C, Pray IW, et al</a>: Epidemiologic characteristics associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen-based test results, real-time reverse transcription polymerase chain reaction (rRT-PCR) cycle threshold values, subgenomic RNA, and viral culture results from university testing. <i>Clin Infect Dis</i> 73(6):e1348-e1355, 2021. doi: 10.1093/cid/ciab303</p></div></li><li class="topic__listitem"><span id="v70338601" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313090/">Wu S, Archuleta S, Lim SM, et al</a>: Serial antigen rapid testing in staff of a large acute hospital. <i>Lancet Infect Dis</i> 22(1):14-15, 2022. doi: 10.1016/S1473-3099(21)00723-4 </p></div></li><li class="topic__listitem"><span id="v70338604" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305720/">Dinnes J, Sharma P, Berhane S</a>: Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. <i>Cochrane Database Sys Rev</i> July 22, 2022. doi: 10.1002/14651858.CD013705.pub3/full</p></div></li></ul></div> </div> </section> </div> </section> <section id="v58252051" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="" class="topic__header--section" data-originaltitle="Treatment"> <span id="v58252052" class="anchor"></span> Treatment of COVID-19 </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v58252055" class="anchor"></span><div class="para"> <p>Supportive care</p></div></li><li class="topic__listitem"><span id="v62110457" class="anchor"></span><div class="para"> <p>Sometimes, for mild to moderate illness with high-risk of severe disease: <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nirmatrelvir/ritonavir</span> combination; <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>remdesivir</span> (short course); <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>molnupiravir</span></p></div></li><li class="topic__listitem"><span id="v62110459" class="anchor"></span><div class="para"> <p>For severe illness: <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>remdesivir</span>; <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dexamethasone</span>; immunomodulators</p></div></li></ul></div><span id="v58252062" class="anchor"></span><div class="para"> <p>Treatment of COVID-19 depends on the severity of illness and the likelihood that the patient will develop severe disease. Treatment guidelines are evolving as new data emerge (see <a rel="nofollow" target="_blank" href="https://www.covid19treatmentguidelines.nih.gov/">National Institutes of Health (NIH) COVID-19 Treatment Guidelines</a>, <a rel="nofollow" target="_blank" href="https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/">Infectious Diseases Society of America (IDSA) Guidelines on the Treatment and Management of Patients with COVID-19</a>, and <a rel="nofollow" target="_blank" href="https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2023.1">World Health Organization (WHO): Therapeutics and COVID-19:Living guideline, 13 January 2023</a>). </p></div><span id="v70338607" class="anchor"></span><div class="para"> <p>The NIH definitions of severity are as follows:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v58252067" class="anchor"></span><div class="para"> <p>Mild illness: Patients who have any signs and symptoms of COVID-19 (eg, fever, cough, sore throat, malaise, headache, muscle pain) but without shortness of breath, dyspnea, hypoxemia, or abnormal chest imaging</p></div></li><li class="topic__listitem"><span id="v58252069" class="anchor"></span><div class="para"> <p>Moderate illness: Patients who have evidence of lower respiratory disease by clinical assessment or imaging, and an oxygen saturation (SpO2) ≥ 94% on room air at sea level</p></div></li><li class="topic__listitem"><span id="v58252071" class="anchor"></span><div class="para"> <p>Severe illness: Patients who have respiratory rate > 30 breaths per minute, SpO2 < 94% on room air at sea level (or, for patients with chronic hypoxemia, a> 3% decrease from baseline), ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) < 300 mmhg, or lung infiltrates> 50%</p></div></li><li class="topic__listitem"><span id="v58252073" class="anchor"></span><div class="para"> <p>Critical illness: Patients who have respiratory failure, septic shock, and/or multiple organ dysfunction</p></div></li></ul></div><span id="v70338608" class="anchor"></span><div class="para"> <p>The effectiveness of particular antiviral drugs and monoclonal antibodies against locally circulating variants is considered when making treatment decisions (see <a rel="nofollow" target="_blank" href="https://opendata.ncats.nih.gov/variant/activity">Open Data Portal: Database of in vitro therapeutic activity against SARS-CoV-2 variants</a>). Treatment options are listed in order of preference based on currently available data and circulating SARS-CoV-2 variants. Treatment choice should be based on drug availability, infrastructure to administer the drug, and patient-specific factors that include symptom duration, potential drug interactions, and liver and renal impairment. There are no data regarding combination treatments with the currently available therapies; therefore, only one anti-SARS-CoV-2 drug should be administered. </p></div><span id="v70338610" class="anchor"></span><div class="para"> <p>Supply limits and administration constraints may require clinicians to prioritize patients who are likely to receive the greatest benefit (eg, preventing hospitalization and death). This would include patients who are infected rather than exposed and unvaccinated, incompletely vaccinated, or vaccinated but not expected to mount an adequate immune response due to immunocompromising conditions.</p></div> <section id="v62110462" class="topic__section HHead"> <h3 class="topic__header--subsection"> <span id="v62110463" class="anchor"></span> Early treatment for patients with mild to moderate COVID-19 who are high risk for progression to severe illness </h3> <div class="topic__content"> <span id="v62110464" class="anchor"></span><div class="para"> <p>These treatments are intended to prevent progression to severe disease in high-risk patients. They are given to patients within a few days of onset of mild to moderate COVID-19 who are ambulatory (or hospitalized for reasons other than COVID-19); treatment options (other than <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>remdesivir</span>) have not been studied in patients hospitalized for COVID-19.</p></div><span id="v62110467" class="anchor"></span><div class="para"> <p><b>Nirmatrelvir,</b> an oral antiviral drug, given in combination with <b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ritonavir</span>,</b> received approval from the US Food and Drug Administration (FDA) for treatment of mild to moderate COVID-19 in adults and Emergency Use Authorization (EUA) for adolescents (≥ 12 years of age weighing ≥ 40 kilograms) who have positive results of direct SARS-CoV-2 viral testing and who are at high risk for progression to severe COVID-19. The <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nirmatrelvir/ritonavir</span> combination should be initiated as soon as possible after diagnosis of COVID-19 and within 5 days of symptom onset. The dosage is two 150-mg tablets of nirmatrelvir and one 100-mg tablet of <span class="genericDrug" data-showrollover="false">ritonavir</span> taken together orally twice a day for 5 days. This drug treatment is not authorized for use for longer than 5 consecutive days. (See also the <a rel="nofollow" target="_blank" href="https://www.fda.gov/media/155050/download">FDA EUA Factsheet</a>.) </p></div><span id="v62110469" class="anchor"></span><div class="para"> <p>Nirmatrelvir is a protease inhibitor that cleaves a SARS-CoV-2 protein and therefore inhibits the virus from replicating. <span class="genericDrug" data-showrollover="false">Ritonavir</span> is a strong cytochrome P450 (CYP) 3A4 inhibitor and acts as a boosting agent; it slows down the metabolism of nirmatrelvir, causing it to remain in the body for a longer duration at higher concentrations. </p></div><span id="v62110470" class="anchor"></span><div class="para"> <p>The <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nirmatrelvir/ritonavir</span> combination was studied in a randomized controlled trial of 2,246 nonhospitalized symptomatic adults ≥ 18 years of age with a prespecified risk factor for progression to severe disease or ≥ 60 years of age regardless of prespecified chronic medical conditions. All patients had not received a COVID-19 vaccine, had not been previously infected with COVID-19, and had a laboratory confirmed diagnosis of SARS-CoV-2 infection. The <span class="genericDrug" data-showrollover="false">nirmatrelvir/ritonavir</span> combination given at ≤ 5 days after symptom onset reduced the proportion of people with COVID-19-related hospitalization or death from any cause through day 28 compared to placebo by 88% (0.8 versus 6.3%) (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="5c814c11-1beb-4997-b35a-6af4178192d8" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">1</a><span id="5c814c11-1beb-4997-b35a-6af4178192d8" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v62110471" class="anchor"></span><div class="para"> <p>Using the <span class="genericDrug" data-showrollover="false">nirmatrelvir/ritonavir</span> combination in people with uncontrolled or undiagnosed HIV-1 infection may lead to HIV-1 drug resistance. The <span class="genericDrug" data-showrollover="false">nirmatrelvir/ritonavir</span> combination may cause liver damage, so caution should be exercised in patients with preexisting liver disease, liver enzyme abnormalities, or hepatitis. The drug is not recommended in patients with severe liver disease. </p></div><span id="v70338619" class="anchor"></span><div class="para"> <p>In patients with moderate renal impairment, which is an estimated creatinine clearance (also called estimated glomerular filtration rate or eGFR) of 30 to 60 mL/minute, the dose is reduced to 150 mg nirmatrelvir (one 150-mg tablet) with 100 mg <span class="genericDrug" data-showrollover="false">ritonavir</span> (one 100-mg tablet), with both tablets taken together twice a day for 5 days. <span class="genericDrug" data-showrollover="false">Nirmatrelvir/ritonavir</span> combination is not recommended in patients with severe kidney impairment (eGFR < 30 mL/minute).</p></div><span id="v70338621" class="anchor"></span><div class="para"> <p>Return of symptoms has been reported in some patients after use of <span class="genericDrug" data-showrollover="false">nirmatrelvir/ritonavir</span>, and PCR and antigen tests for SARS-CoV-2 can become positive again, even in patients who remain asymptomatic. Additional treatment is not currently recommended, but patients should be advised to re-isolate if rebound symptoms or tests occur. (See also <a rel="nofollow" target="_blank" href="http://emergency.cdc.gov/han/2022/han00467.asp">CDC: COVID-19 Rebound After Paxlovid Treatment</a>.)</p></div><span id="v62110472" class="anchor"></span><div class="para"> <p>The <span class="genericDrug" data-showrollover="false">nirmatrelvir/ritonavir</span> combination drug has a variety of serious known and possible drug interactions; concomitant drugs must be screened for these prior to initiation of treatment. For a list of these drug interactions see the <a rel="nofollow" target="_blank" href="https://www.fda.gov/media/155050/download">FDA EUA Fact Sheet</a>.</p></div><span id="v62110479" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Remdesivir</span>,</b> an intravenous antiviral drug, is used to treat mild to moderate COVID-19 in adults and adolescents (≥ 12 years old and weighing ≥ 40 kilograms) who have positive results of direct SARS-CoV-2 viral testing and who are at high risk for progression to severe COVID-19. It should be initiated as soon as possible and within 7 days of symptom onset. The dose of a 3-day course of <span class="genericDrug" data-showrollover="false">remdesivir</span> is 200 mg IV on day 1 and 100 mg IV on days 2 and 3. The course can be extended to 5 days for patients who progress to severe disease.</p></div><span id="v70338625" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Remdesivir</span> was studied for this indication in a randomized controlled trial of 562 nonhospitalized patients age ≥ 12 years of age with symptomatic COVID-19 at high risk for progression to severe disease and who had not received a COVID-19 vaccine. <span class="genericDrug" data-showrollover="false">Remdesivir</span> given for 3 days and started within 7 days of symptom onset reduced hospitalization or death rates through day 28 compared to placebo by 87% (0.7 versus 5.3%) (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="c9bd83c0-9f02-4289-99f0-73c1e30a0a64" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">2</a><span id="c9bd83c0-9f02-4289-99f0-73c1e30a0a64" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v62110481" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Molnupiravir</span>,</b> an oral antiviral drug, is a nucleoside analogue that works by introducing errors into the SARS-CoV-2 viral genome, which inhibits viral replication. It has received FDA EUA for treatment of mild to moderate COVID-19 in nonhospitalized adults ≥ 18 years of age who have positive results of direct SARS-CoV-2 viral testing and who are at high risk for progression to severe disease, including hospitalization or death, and for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate. <span class="genericDrug" data-showrollover="false">Molnupiravir</span> should be initiated as soon as possible after diagnosis of COVID-19 and within 5 days of symptom onset. <span class="genericDrug" data-showrollover="false">Molnupiravir</span> is administered as four 200-mg capsules taken orally every 12 hours for 5 days. It is not authorized for use for longer than 5 consecutive days. (See also the <a rel="nofollow" target="_blank" href="https://www.fda.gov/media/155054/download">FDA EUA Fact Sheet for Molnupiravir</a>.) </p></div><span id="v62110486" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Molnupiravir</span> may have an effect on the emergence of new SARS-CoV-2 variants based on a theoretical concern; however, the risk is believed to be low based on available genotoxicity data and the limited 5-day treatment course. <span class="genericDrug" data-showrollover="false">Molnupiravir</span> is not authorized for use in patients < 18 years of age because it may affect bone and cartilage growth. <span class="genericDrug" data-showrollover="false">Molnupiravir</span> is not recommended for use during pregnancy because animal reproduction studies suggested that <span class="genericDrug" data-showrollover="false">molnupiravir</span> may cause fetal harm when administered to pregnant patients. Females of childbearing potential are advised to use a reliable method of birth control correctly and consistently during treatment with <span class="genericDrug" data-showrollover="false">molnupiravir</span> and for 4 days after the final dose. Males of reproductive potential who are sexually active with females of childbearing potential are advised to use a reliable method of birth control correctly and consistently during treatment with <span class="genericDrug" data-showrollover="false">molnupiravir</span> and for at least 3 months after the final dose.</p></div><span id="v62110484" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Molnupiravir</span> was studied in a randomized, double-blind, placebo-controlled clinical trial of 1433 nonhospitalized patients ≥ 18 years of age with mild to moderate COVID-19 at high risk for progression to severe COVID-19 and/or hospitalization and who had not received a COVID-19 vaccine. <span class="genericDrug" data-showrollover="false">Molnupiravir</span> given for 5 days and started within 5 days of symptom onset reduced by 30% hospitalization or death rates through day 29 compared to placebo (6.8 versus 9.7%) (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="93edb44b-af6c-48cf-986a-32f06234c5a6" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">3</a><span id="93edb44b-af6c-48cf-986a-32f06234c5a6" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v70338641" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bamlanivimab/etesevimab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>casirivimab/imdevimab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>sotrovimab</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bebtelovimab</span></b> are neutralizing anti-SARS-CoV-2 monoclonal antibody (mAb) therapies. The FDA currently recommends against their use in treatment of COVID-19 because the dominant Omicron subvariants are resistant to their neutralizing activity (see <a rel="nofollow" target="_blank" href="https://www.covid19treatmentguidelines.nih.gov/therapies/anti-sars-cov-2-antibody-products/anti-sars-cov-2-monoclonal-antibodies/?utm_source=site&utm_medium=home&utm_campaign=highlights">NIH: Anti-SARS-CoV-2 Monoclonal Antibodies</a>). </p></div> </div> </section> <section id="v62110487" class="topic__section HHead"> <h3 class="topic__header--subsection"> <span id="v62110488" class="anchor"></span> Treatment for patients with severe COVID-19 </h3> <div class="topic__content"> <span id="v62110489" class="anchor"></span><div class="para"> <p>Recommended treatment options for severe infection include the antiviral drug <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>remdesivir</span>, the corticosteroid <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dexamethasone</span>, and additional immunomodulatory drugs such as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>baricitinib</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tocilizumab</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>sarilumab</span>. These may be used in combination, and treatment decisions should take into account the patient's phase of illness, often characterized by the degree of hypoxia and respiratory support. </p></div><span id="v64013771" class="anchor"></span><div class="para"> <p>Antiviral drugs are more likely to provide benefit earlier in the course when illness is a result of active viral replication, whereas anti-inflammatory and immunomodulatory therapies are better suited for later in the course when the host inflammatory response and immune dysregulation are driving the disease state. (Also see <a rel="nofollow" target="_blank" href="https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/hospitalized-adults--therapeutic-management/">NIH: Therapeutic Management of Hospitalized Adults With COVID-19</a>.)</p></div><span id="v62110491" class="anchor"></span><div class="para"> <p><b>For patients requiring supplemental oxygen but not additional respiratory support,</b> treatment options include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v62110494" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Remdesivir</span> alone</p></div></li><li class="topic__listitem"><span id="v62110496" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dexamethasone</span> alone</p></div></li><li class="topic__listitem"><span id="v62110498" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Remdesivir</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dexamethasone</span></p></div></li></ul></div><span id="v62110499" class="anchor"></span><div class="para"> <p>The antiviral drug <b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>remdesivir</span></b> is used to treat adult and pediatric patients ≥ 28 days of age and weighing ≥ 3 kg who require hospitalization for COVID-19. The recommended dosage for adults and pediatric patients weighing ≥ 40 kg is a single loading dose of 200 mg on Day 1 via intravenous infusion followed by once-a-day maintenance doses of 100 mg from Day 2 via intravenous infusion. The recommended dosage for pediatric patients ≥ 28 days of age and weighing 3 kg to less than 40 kg is a single loading dose of 5 mg/kg on Day 1 via intravenous infusion followed by once-a-day maintenance doses of 2.5 mg/kg from Day 2 via intravenous infusion. The recommended treatment duration is 5 days but is approved for use up to 10 days in patients who require invasive mechanical ventilation and/or extracorporeal membrane oxygenation (ECMO). Benefits of antiviral treatment in this group though are inconclusive. </p></div><span id="v66414823" class="anchor"></span><div class="para"> <p>In a large randomized clinical trial (ACTT-1), <span class="genericDrug" data-showrollover="false">remdesivir</span> was associated with earlier clinical improvement for patients requiring supplemental oxygen but not mechanical ventilation or other higher levels of support (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="44a00c00-6bc9-476b-a62d-6fa1b604e348" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">4</a><span id="44a00c00-6bc9-476b-a62d-6fa1b604e348" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). This improved time to recovery was also observed in an outpatient randomized controlled trial (PINETREE) (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="118cf5b0-c7e5-4a75-98a9-f9249feceeba" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">2</a><span id="118cf5b0-c7e5-4a75-98a9-f9249feceeba" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). However, benefit was not observed in 2 open-label trials (Solidarity [ <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="8fa843bc-7dc5-4481-aeac-6c94f1281db4" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">5</a><span id="8fa843bc-7dc5-4481-aeac-6c94f1281db4" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>] and DisCoVeRy [ <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="6749d13c-31a2-4513-85ff-2ee0568b18da" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">6</a><span id="6749d13c-31a2-4513-85ff-2ee0568b18da" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>]).</p></div><span id="v64013773" class="anchor"></span><div class="para"> <p>Overall, studies of <span class="genericDrug" data-showrollover="false">remdesivir</span> support its use early in infection (prior to days 7 to 10) when active viral replication is more likely to be contributing to illness. <span class="genericDrug" data-showrollover="false">Remdesivir</span> can also be considered in patients who are hospitalized but not requiring supplemental oxygen, although data are lacking in this population. <span class="genericDrug" data-showrollover="false">Remdesivir</span> is not recommended for patients with an eGFR < 30 mL/minute. Renal function should be monitored before and during <span class="genericDrug" data-showrollover="false">remdesivir</span> treatment. (See also the <a rel="nofollow" target="_blank" href="https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/remdesivir/">NIH treatment guidelines on remdesivir</a>.)</p></div><span id="v62110502" class="anchor"></span><div class="para"> <p>The corticosteroid <b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dexamethasone</span></b> (at a dosage of 6 mg once per day for up to 10 days or until hospital discharge, whichever comes first) is generally recommended in patients with COVID-19 who require supplemental oxygen, but its use is not recommended in patients who do not require supplemental oxygen. <span class="genericDrug" data-showrollover="false">Dexamethasone</span> showed a survival benefit for those requiring supplemental oxygen or mechanical ventilation in the RECOVERY trial (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="7151e344-0ee5-4a20-a31a-09391385d228" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">7</a><span id="7151e344-0ee5-4a20-a31a-09391385d228" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Its benefit is likely to be greatest in patients whose illness is due to the inflammatory response from infection. If <span class="genericDrug" data-showrollover="false">dexamethasone</span> is not available, other corticosteroids (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prednisone</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methylprednisolone</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydrocortisone</span>) may be used. </p></div><span id="v62110504" class="anchor"></span><div class="para"> <p>The combination of <span class="genericDrug" data-showrollover="false">remdesivir</span> and <span class="genericDrug" data-showrollover="false">dexamethasone</span> is commonly used in hospitalized patients requiring supplemental oxygen within the first 10 days of illness when both viral replication and host inflammation may be contributing to the clinical presentation.</p></div><span id="v62110505" class="anchor"></span><div class="para"> <p><b>For patients requiring noninvasive ventilation (including high flow oxygen delivery systems)</b></p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v62110508" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dexamethasone</span> is recommended for all patients.</p></div></li><li class="topic__listitem"><span id="v62110510" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Remdesivir</span> may be added with particular consideration for patients within 7 to 10 days of symptom onset.</p></div></li><li class="topic__listitem"><span id="v62110512" class="anchor"></span><div class="para"> <p>Additional immunomodulatory drugs should be considered, particularly for patients with rapid deterioration or signs of systemic inflammation.</p></div></li></ul></div><span id="v62110513" class="anchor"></span><div class="para"> <p>Additional immunomodulators include the JAK inhibitor <b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>baricitinib</span></b> (or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tofacitinib</span> if unavailable) or the IL-6 inhibitor <b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tocilizumab</span></b> (or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>sarilumab</span> if unavailable). These recommendations are based on subgroup analyses of numerous randomized (COV-BARRIER [ <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="ce2b2b90-c3c6-465f-b8f1-26d80a4c4aae" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">8</a><span id="ce2b2b90-c3c6-465f-b8f1-26d80a4c4aae" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>], ACTT-2 [ <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="4d86000c-2ed9-4fc7-910a-266ab206cfe7" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">9</a><span id="4d86000c-2ed9-4fc7-910a-266ab206cfe7" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>]) and open label (REMAP-CAP [ <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="95c593c9-2e1f-4989-9964-0ce0c9e5edac" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">10</a><span id="95c593c9-2e1f-4989-9964-0ce0c9e5edac" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>], RECOVERY [ <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="0c47e884-28cb-401a-9e37-67174718eb14" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">11</a><span id="0c47e884-28cb-401a-9e37-67174718eb14" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>]) clinical trials that showed survival benefit with addition of one of these drugs in patients requiring this level of respiratory support. These drugs are potent immunosuppressants, and the potential benefit should be weighed against the additional immunosuppressive risk in patients with suspicion of a concomitant serious bacterial or fungal infection or at high risk for opportunistic infections due to an underlying immunosuppressive condition. See <a rel="nofollow" target="_blank" href="https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/summary-recommendations/">NIH treatment guidelines on immunomodulators</a> for further details regarding appropriate patient selection for these therapies.</p></div><span id="v62110515" class="anchor"></span><div class="para"> <p><b>For patients requiring mechanical ventilation or ECMO,</b> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dexamethasone</span> is recommended for all patients. The addition of tociluzumab should be considered for patients within 24 hours of admission to the intensive care unit (ICU).</p></div><span id="v62110516" class="anchor"></span><div class="para"> <p>Many therapies have been considered and <i>are not currently recommended</i> for the treatment or prevention of COVID-19:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v86116749" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Vilobelimab</span> is an anti-complement (anti-C5a) monoclonal antibody that received an FDA EUA in April 2023 for treatment of COVID-19 in hospitalized adults when initiated within 48 hours of receiving invasive mechanical ventilation or extracorporeal membrane oxygenation. Data about this agent are limited; in a single randomized trial, the presence of a significant effect on 28-day mortality varied by analysis (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="5b6b5043-ce6d-429b-9307-3f11d20d3bd0" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">12</a><span id="5b6b5043-ce6d-429b-9307-3f11d20d3bd0" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Clinical recommendations for its use have not been published. </p></div></li><li class="topic__listitem"><span id="v62110519" class="anchor"></span><div class="para"> <p>Convalescent plasma is not currently recommended for the treatment of patients hospitalized with COVID-19. Data from a number of randomized clinical trials (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="cba0a5a0-8f8a-4001-b32a-a4032765bde8" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">13</a><span id="cba0a5a0-8f8a-4001-b32a-a4032765bde8" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>) and a large registry associated with an expanded access program failed to show a meaningful benefit in this population and suggest a potential association with increased need for mechanical ventilation. It may be considered in nonhospitalized patients with mild to moderate disease and high risk of progression to severe disease if no other treatment options are available. </p></div></li><li class="topic__listitem"><span id="v62110521" class="anchor"></span><div class="para"> <p>Nonspecific immunoglobulin (IVIG) and mesenchymal stem cell therapy are also not recommended. </p></div></li><li class="topic__listitem"><span id="v62110523" class="anchor"></span><div class="para"> <p>Additional immunomodulatory therapies, including interferons, kinase inhibitors, and interleukin inhibitors have been used, but there are insufficient data to recommend their routine use outside of clinical trials. </p></div></li><li class="topic__listitem"><span id="v62110525" class="anchor"></span><div class="para"> <p>Other drugs that have been used include <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>azithromycin</span> and antiretrovirals, but there are insufficient data to support the use of these drugs outside of clinical trials. </p></div></li><li class="topic__listitem"><span id="v62110527" class="anchor"></span><div class="para"> <p>Multiple clinical trials of the HIV retroviral <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>lopinavir/ritonavir</span> and the anti-malarial drugs <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span> have shown these drugs to be without benefit (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="9579909b-0810-45c5-b9b8-6403e723d767" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">14</a><span id="9579909b-0810-45c5-b9b8-6403e723d767" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="3404677c-1ec6-4e71-8ceb-8e9e310bc4db" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">15</a><span id="3404677c-1ec6-4e71-8ceb-8e9e310bc4db" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). The combined lack of benefit and toxicities associated with <span class="genericDrug" data-showrollover="false">chloroquine</span> and <span class="genericDrug" data-showrollover="false">hydroxychloroquine</span> led to recommendations that they not be used for treatment of COVID-19 (see <a rel="nofollow" target="_blank" href="https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/chloroquine-or-hydroxychloroquine-and-or-azithromycin/">NIH COVID-19 Treatment Guidelines: Chloroquine or Hydroxychloroquine and/or Azithromycin</a>). </p></div></li><li class="topic__listitem"><span id="v62110529" class="anchor"></span><div class="para"> <p>There are also no randomized clinical trials documenting the usefulness of the antiparasitic drug <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ivermectin</span> for the prevention or treatment of COVID-19 (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="e25cf470-803d-4f6e-8dea-db9500f16c1d" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">16</a><span id="e25cf470-803d-4f6e-8dea-db9500f16c1d" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). A recent large randomized, placebo-controlled study showed no effect of <span class="genericDrug" data-showrollover="false">ivermectin</span> (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107" data-toggle="tooltip" title="Treatment references" data-id="8c69bb08-a4a7-4ea9-8e0d-4ca9dc745896" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">17</a><span id="8c69bb08-a4a7-4ea9-8e0d-4ca9dc745896" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v58252107"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). The FDA and other organizations have issued warnings about toxicity from the inappropriate use of <span class="genericDrug" data-showrollover="false">ivermectin</span> preparations intended for large animal use (see <a rel="nofollow" target="_blank" href="https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19">FDA: Why You Should Not Use Ivermectin to Treat or Prevent COVID-19</a>). </p></div></li><li class="topic__listitem"><span id="v62110533" class="anchor"></span><div class="para"> <p>The selective serotonin reuptake inhibitor (SSRI) <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fluvoxamine</span> has been studied in 2 randomized clinical trials of symptomatic ambulatory patients with COVID-19 with unclear benefit and potential trend to increased harm; therefore, it is not recommended for use outside of a clinical trial. </p></div></li></ul></div><span id="v62110534" class="anchor"></span><div class="para"> <p>An NIH panel concluded there is insufficient evidence to recommend either for or against the use of ECMO in adults with COVID-19 and refractory hypoxemia (see <a rel="nofollow" target="_blank" href="https://www.covid19treatmentguidelines.nih.gov/management/critical-care-for-adults/ecmo-for-adults/">NIH COVID-19 Treatment Guidelines: Extracorporeal Membrane Oxygenation [May 31, 2022]</a>).</p></div><span id="v62110536" class="anchor"></span><div class="para"> <p>Complications of COVID-19 illness should be treated as they arise. Hospitalized patients with COVID-19 may be at increased risk for thromboembolic events. Guidelines around managing this increased risk are continually evolving as data emerge (see <a rel="nofollow" target="_blank" href="https://www.covid19treatmentguidelines.nih.gov/therapies/statement-on-anticoagulation-in-hospitalized-patients/">NIH: The COVID-19 Treatment Guidelines Panel's Statement on Anticoagulation in Hospitalized Patients With COVID-19</a>). Currently, therapeutic <a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392038" data-toggle="tooltip" title="Anticoagulants" data-id="023c7b12-6702-4955-89a2-bc3ceea41703" data-itemid="99f36709-190d-404e-bf6d-a0b1f6a706f0">anticoagulation</a><span id="023c7b12-6702-4955-89a2-bc3ceea41703" class="d-none xref"> <span class="tooltip-container"> <a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392038"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulants </span> Almost all patients with deep venous thrombosis (DVT) are given anticoagulants and in rare cases thrombolytics. A number of anticoagulants are effective for management of deep venous thrombosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> should be considered in nonpregnant, hospitalized patients requiring supplemental oxygen but not intensive care if they have an elevated D-dimer and no serious bleeding risk. The risk of an adverse event from bleeding outweighs the potential benefit in critically ill patients. Pharmacologic venous thromboembolism prophylaxis should be considered for all other hospitalized patients.</p></div><span id="v62110539" class="anchor"></span><div class="para"> <p>Drugs such as angiotensin-converting enzyme (ACE) inhibitor or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>angiotensin II</span> receptor blocker (ARB) therapy should be continued if needed for concomitant medical conditions but not started as treatment for COVID-19. There is no evidence that use of nonsteroidal anti-inflammatory drugs (NSAIDs) is linked to worse outcomes, and either <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>acetaminophen</span> or NSAIDs can be used during the treatment of COVID-19.</p></div><span id="v62110540" class="anchor"></span><div class="para"> <p>Respiratory management of the nonintubated and intubated COVID-19 patient should take into consideration the tendency toward hypoxia. Nonpharmacologic adjunctive measures such as frequent repositioning and ambulation may be helpful.</p></div> </div> </section> <section id="v58252106" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="" class="topic__header--subsection"> <span itemprop="name" id="v58252107" class="anchor"></span> Treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v70338656" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908851/">Hammond J, Leister-Tebbe H, Gardner A, et al</a>: Oral <span class="genericDrug" data-showrollover="false">nirmatrelvir</span> for high-risk, nonhospitalized adults with Covid-19. <i>N Engl J Med</i> 386(15):1397-1408, 2022. doi: 10.1056/NEJMoa2118542</p></div></li><li class="topic__listitem"><span id="v62110547" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757570/">Gottlieb RL, Vaca CE, Paredes R et al</a>: Early <span class="genericDrug" data-showrollover="false">remdesivir</span> to prevent progression to severe covid-19 in outpatients. <i>N Engl J Med</i> 386(4):305-315, 2022. doi: 10.1056/NEJMoa2116846</p></div></li><li class="topic__listitem"><span id="v70338660" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693688/">Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al</a>: <span class="genericDrug" data-showrollover="false">Molnupiravir</span> for oral treatment of Covid-19 in nonhospitalized Patients. <i>N Engl J Med</i> 386(6):509-520, 2022. doi: 10.1056/NEJMoa2116044</p></div></li><li class="topic__listitem"><span id="v62110551" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262788/">Beigel JH, Tomashek KM, Dodd LE, et al</a>: <span class="genericDrug" data-showrollover="false">Remdesivir</span> for the treatment of Covid-19 - final report. <i>N Engl J Med</i> 383(19):1813-1826, 2020. doi: 10.1056/NEJMoa2007764</p></div></li><li class="topic__listitem"><span id="v70338664" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060606/">WHO Solidarity Trial Consortium</a>: <span class="genericDrug" data-showrollover="false">Remdesivir</span> and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. <i>Lancet</i> 399(10339):1941-1953, 2022. doi: 10.1016/S0140-6736(22)00519-0</p></div></li><li class="topic__listitem"><span id="v70338668" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439621/">Ader F, Bouscambert-Duchamp M, Hites M, et al</a>: <span class="genericDrug" data-showrollover="false">Remdesivir</span> plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. <i>Lancet Infect Dis</i> 22(2):209-221, 2022. doi: 10.1016/S1473-3099(21)00485-0</p></div></li><li class="topic__listitem"><span id="v62110555" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383595/">RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, et al</a>: <span class="genericDrug" data-showrollover="false">Dexamethasone</span> in hospitalized patients with Covid-19. <i>N Engl J Med</i> 384(8):693-704, 2021. doi: 10.1056/NEJMoa2021436</p></div></li><li class="topic__listitem"><span id="v86116754" class="anchor"></span><div class="para"> <p>8. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409066/">Marconi VC, Ramanan AV, de Bono S, et al</a>: Efficacy and safety of <span class="genericDrug" data-showrollover="false">baricitinib</span> for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial [published correction appears in <i>Lancet Respir Med</i> 2021 Oct;9(10):e102]. <i>Lancet Respir Med</i> 9(12):1407-1418, 2021. doi:10.1016/S2213-2600(21)00331-3</p></div></li><li class="topic__listitem"><span id="v86116758" class="anchor"></span><div class="para"> <p>9. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745180/">Kalil AC, Patterson TF, Mehta AK, et al</a>: <span class="genericDrug" data-showrollover="false">Baricitinib</span> plus <span class="genericDrug" data-showrollover="false">remdesivir</span> for hospitalized adults with Covid-19. <i>N Engl J Med</i> 384(9):795-807, 2021. doi:10.1056/NEJMoa2031994</p></div></li><li class="topic__listitem"><span id="v86116763" class="anchor"></span><div class="para"> <p>10. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953461/">REMAP-CAP Investigators, Gordon AC, Mouncey PR, et al</a>: Interleukin-6 receptor antagonists in critically ill patients with Covid-19. <i>N Engl J Med</i> 384(16):1491-1502, 2021. doi:10.1056/NEJMoa2100433</p></div></li><li class="topic__listitem"><span id="v86116766" class="anchor"></span><div class="para"> <p>11. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383595/">RECOVERY Collaborative Group, Horby P, Lim WS, et al</a>: <span class="genericDrug" data-showrollover="false">Dexamethasone</span> in hospitalized patients with Covid-19. <i>N Engl J Med</i> 384(8):693-704, 2021. doi:10.1056/NEJMoa2021436</p></div></li><li class="topic__listitem"><span id="v86116770" class="anchor"></span><div class="para"> <p>12. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451499/">Vlaar APJ, Witzenrath M, van Paassen P, et al</a>: Anti-C5a antibody (<span class="genericDrug" data-showrollover="false">vilobelimab</span>) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. <i>Lancet Respir Med</i> 10(12):1137-1146, 2022. doi:10.1016/S2213-2600(22)00297-1</p></div></li><li class="topic__listitem"><span id="v70338671" class="anchor"></span><div class="para"> <p>13.<a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911095/"> Janiaud P, Axfors C, Schmitt AM, et al</a>: Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19: A systematic review and meta-analysis. <i>JAMA</i> 325(12);1185-1195, 2021, doi: 10.1001/jama.2021.2747</p></div></li><li class="topic__listitem"><span id="v86116774" class="anchor"></span><div class="para"> <p>14. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653542/">Self WH, Semler MW, Leither LM, et al</a>. Effect of <span class="genericDrug" data-showrollover="false">hydroxychloroquine</span> on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial. <i>JAMA</i> 324(21):2165-2176, 2020. doi:10.1001/jama.2020.22240</p></div></li><li class="topic__listitem"><span id="v86116778" class="anchor"></span><div class="para"> <p>15. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556338/">RECOVERY Collaborative Group, Horby P, Mafham M, et al</a>. Effect of <span class="genericDrug" data-showrollover="false">hydroxychloroquine</span> in hospitalized patients with Covid-19. <i>N Engl J Med</i> 383(21):2030-2040, 2020. doi:10.1056/NEJMoa2022926</p></div></li><li class="topic__listitem"><span id="v62110559" class="anchor"></span><div class="para"> <p>16. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406455/">Popp M, Stegemann M, Metzendorf MI, et al</a>: <span class="genericDrug" data-showrollover="false">Ivermectin</span> for preventing and treating COVID-19. <i>Cochrane Database Syst Rev.</i> 7(7):CD015017, 2021. doi: 10.1002/14651858.CD015017.pub2</p></div></li><li class="topic__listitem"><span id="v70338674" class="anchor"></span><div class="para"> <p>17. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006771/">Reis G,Silva EASM, Silva DCM, et al</a>: Effect of early treatment with <span class="genericDrug" data-showrollover="false">ivermectin</span> among patients with COVID-19. <i>N Engl J Med</i> 386:1721-1731, 2022. doi: 10.1056/NEJMoa2115869</p></div></li></ul></div> </div> </section> </div> </section> <section id="v70338676" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v70338677" class="anchor"></span> Post–COVID-19 Infection </h2> <div class="topic__content"> <span id="v70338678" class="anchor"></span><div class="para"> <p>Viral PCR tests in patients may remain positive for at least 3 months regardless of symptoms. However, even patients with lingering symptoms are generally not considered infectious, as virus is rarely if ever able to be cultured from the upper respiratory tract of patients after 10 days of illness. </p></div><span id="v70338679" class="anchor"></span><div class="para"> <p>Although infection with coronaviruses may confer some degree of immunity to reinfection, the duration and effectiveness of immunity following COVID-19 remain difficult to quantify and depend upon multiple host and viral factors. Patients who have had COVID-19, including people with prolonged post-COVID-19 symptoms, are still recommended to receive all eligible vaccinations to reduce the risk of reinfection. They can do so when clinically recovered from infection and completing the isolation period. Neutralizing antibodies are detected in most patients following SARS-COV-2 infection, but the levels of these are more variable than in people after vaccinations. These likely provide protection against clinically apparent reinfection in most immunocompetent people for at least 3 and up to 6 months, but this time frame may be shorter if a new antigenically distinct variant emerges. Symptoms associated with reinfection tend to be similar to or milder than initial infections. </p></div> <section id="v70338683" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v70338684" class="anchor"></span> Post–COVID-19 infection reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v86116783" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561429/">Zhong D, Xiao S, Debes AK, et al</a>: Durability of antibody levels after vaccination with mRNA SARS-CoV-2 vaccine in individuals with or without prior infection. <i>JAMA</i> 326(24):2524-2526, 2021. doi:10.1001/jama.2021.19996</p></div></li></ul></div> </div> </section> </div> </section> <section id="v58252121" class="topic__section FHead" itemprop="primaryPrevention" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="" class="topic__header--section" data-originaltitle="Prevention"> <span id="v58252122" class="anchor"></span> Prevention of COVID-19 </h2> <div class="topic__content"> <section id="v58252147" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v58252148" class="anchor"></span> COVID-19 vaccination </h3> <div class="topic__content"> <span id="v70338692" class="anchor"></span><div class="para"> <p>For a detailed discussion of the vaccines approved in the United States, see <a href="./{15803A40-86F8-457C-9891-8DE8532EDB52}.html" data-toggle="tooltip" title="COVID-19 Vaccine" data-id="4f5735ad-446f-421b-bfbc-1ff2b6e99222" data-itemid="15803a40-86f8-457c-9891-8de8532edb52">COVID-19 vaccine</a><span id="4f5735ad-446f-421b-bfbc-1ff2b6e99222" class="d-none xref"> <span class="tooltip-container"> <a href="./{15803A40-86F8-457C-9891-8DE8532EDB52}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> COVID-19 Vaccine </span> COVID-19 vaccines provide protection against COVID-19, the disease caused by infection with the SARS-CoV-2 virus. Vaccination is the most effective strategy to prevent severe illness and death... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. </p></div><span id="v62110600" class="anchor"></span><div class="para"> <p>Vaccination is the most effective way to prevent severe illness and death from COVID-19, including from the Delta and Omicron variants. In the United States in the fall of 2021, unvaccinated people were much more likely to die from COVID-19 than vaccinated people (with booster) (<a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v70338720" data-toggle="tooltip" title="Prevention reference" data-id="65352ea8-8d57-4f80-86c4-c8919d31a1c0" data-itemid="d88c399d-ac91-44cd-a31a-0e71b2f9c3c3">1</a><span id="65352ea8-8d57-4f80-86c4-c8919d31a1c0" class="d-none xref"> <span class="tooltip-container"> <a href="./{D88C399D-AC91-44CD-A31A-0E71B2F9C3C3}.html#v70338720"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention reference </span> COVID-19 is a respiratory illness caused by the novel coronavirus SARS-CoV-2. Infection may be asymptomatic or have symptoms ranging from mild upper respiratory symptoms to acute respiratory... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v71476633" class="anchor"></span><div class="para"> <p>In the United States, <a rel="nofollow" target="_blank" href="https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#table-01">the CDC recommends nonimmunocompromised people</a> ages 12 years and older receive 1 dose of the updated 2023–2024 <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>SARS-CoV-2 virus (COVID-19) mRNA vaccine</span> from either manufacturer (Moderna or Pfizer-BioNTech) or 1 or 2 doses (depending on vaccination history) of the updated 2023-2024 <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>SARS-CoV-2 virus (COVID-19) recombinant spike protein nanoparticle vaccine</span> produced by Novavax (see <a rel="nofollow" target="_blank" href="https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html">CDC: Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States</a>). Children ages 6 months to 4 years should receive 1 to 3 doses of an mRNA 2023–2024 formulation (recommended doses and manufacturer vary depending on vaccination history), and children 5 to 11 years should receive 1 dose regardless of vaccination history of either mRNA 2023–2024 formulation. The CDC also recommends adults ages 65 years and over receive an additional updated 2023-2024 COVID-19 vaccine dose (see <a rel="nofollow" target="_blank" href="https://www.cdc.gov/media/releases/2024/s-0228-covid.html">CDC: Older Adults Now Able to Receive Additional Dose of Updated COVID-19 Vaccine</a>). Guidance for people who are moderately or severely immunocompromised can also be found at the <a rel="nofollow" target="_blank" href="https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#table-02">CDC website</a>. The updated 2023–­2024 vaccines target the XBB.1.5 Omicron variant. The 2023–­2024 formulation replaces the COVID-19 monovalent vaccines that targeted the original SARS-CoV-2 strain and the bivalent vaccines that targeted both the original virus and BA.4/BA.5 Omicron subvariants.</p></div><span id="v62110597" class="anchor"></span><div class="para"> <p>Multiple COVID-19 vaccines are currently in use worldwide. For more information on global vaccine approvals and clinical trials, see the <a rel="nofollow" target="_blank" href="https://www.unicef.org/supply/covid-19-vaccine-market-dashboard">UNICEF COVID-19 Vaccine Market Dashboard</a> and the World Health Organization’s <a rel="nofollow" target="_blank" href="https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines">COVID-19 vaccine tracker and landscape</a>. </p></div><span id="v62110579" class="anchor"></span><div class="para"> <p><b>mRNA vaccines</b> do not contain viral antigen but rather deliver a small, synthetic piece of mRNA that encodes for the desired target antigen (the spike protein). After being taken up by cells of the immune system, the vaccine mRNA degrades after instructing the cell to produce viral antigen. The antigen is then released and triggers the desired immune response to prevent severe infection upon subsequent exposure to the actual virus. </p></div><span id="v70338702" class="anchor"></span><div class="para"> <p><b>Adenovirus vector vaccines</b> contain a piece of the DNA, or genetic material, that is used to make the distinctive “spike” protein of the SARS-CoV-2 virus, which then triggers the desired immune response.</p></div><span id="v70338703" class="anchor"></span><div class="para"> <p><b>Protein subunit adjuvanted vaccines</b> contain a recombinant SARS-COV-2 spike protein along with an adjuvant that triggers the desired immune response. This is a classic vaccine approach that has been used in the United States for over 30 years.</p></div><span id="v70338704" class="anchor"></span><div class="para"> <p>Two mRNA vaccines (2023–­2024 formulations of Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine), and one protein subunit adjuvanted vaccine (2023–2024 formulation of Novavax COVID-19 Vaccine, Adjuvanted) are used in the United States (see <a rel="nofollow" target="_blank" href="https://www.cdc.gov/vaccines/covid-19/index.html">CDC: COVID-19 Vaccination Clinical & Professional Resources)</a>. As of May 6, 2023, the adenovirus vector vaccine (Ad26.COV2.S) is no longer available for use in the United States due to the risk of serious adverse events. There is a plausible causal relationship between the adenovirus vector vaccine and a rare and serious adverse event—blood clots with low platelets (vaccine-induced thrombosis with thrombocytopenia syndrome, or VITTS). </p></div> </div> </section> <section id="v70338708" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v70338709" class="anchor"></span> Exposure prevention </h3> <div class="topic__content"> <span id="v70338710" class="anchor"></span><div class="para"> <p>In addition to staying up to date with COVID-19 vaccines, people can avoid being exposed to the virus by washing hands frequently, wearing face masks, maintaining social distance, avoiding poorly ventilated spaces and crowds, and taking other steps <a rel="nofollow" target="_blank" href="https://www.cdc.gov/respiratory-viruses/guidance/respiratory-virus-guidance.html">recommended by the Centers for Disease Control and Prevention (CDC)</a>. People should also have COVID-19 testing if they are exposed to an infected individual or have symptoms. Symptomatic individuals should follow recommendations for isolation.</p></div><span id="v70338715" class="anchor"></span><div class="para"> <p>To help prevent spread of SARS-CoV-2 from suspected cases, health care practitioners should use standard, contact, and airborne precautions with eye protection. Airborne precautions are particularly relevant for patients undergoing aerosol-generating procedures. </p></div> </div> </section> <section id="v70338719" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="" class="topic__header--subsection"> <span itemprop="name" id="v70338720" class="anchor"></span> Prevention reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v70338723" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e2.htm#T1_down">Johnson AG, Amin AB, Ali AR, et al</a>: COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of delta and Omicron variant emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. <i>MMWR Morb Mortal Wkly Rep</i> 71:132–138. 2022. doi: 10.15585/mmwr.mm7104e2</p></div></li></ul></div> </div> </section> </div> </section> <section id="v58252229" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v58252230" class="anchor"></span> More Information </h2> <div class="topic__content"> <span id="v58252231" class="anchor"></span><div class="para"> <p>The following English-language resources may be useful. Please note that THE MANUAL is not responsible for the content of these resources.</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v62110611" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://covid.cdc.gov/covid-data-tracker/#datatracker-home">CDC: COVID Data Tracker</a></p></div></li><li class="topic__listitem"><span id="v58252243" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.cdc.gov/vaccines/covid-19/index.html">CDC: COVID-19 Vaccination Clinical & Professional Resources</a></p></div></li><li class="topic__listitem"><span id="v58252246" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html">CDC: Healthcare Workers: Information on COVID-19</a></p></div></li><li class="topic__listitem"><span id="v58252261" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance">WHO: Coronavirus disease (COVID-19) technical guidance</a></p></div></li><li class="topic__listitem"><span id="v58252264" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/">WHO: Novel Coronavirus (COVID-2019) situation reports</a></p></div></li><li class="topic__listitem"><span id="v58252267" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.covid19treatmentguidelines.nih.gov/">National Institutes of Health (NIH) COVID-19 Treatment Guidelines</a></p></div></li><li class="topic__listitem"><span id="v58252270" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/">Infectious Diseases Society of America (IDSA) Guidelines on the Treatment and Management of Patients with COVID-19</a></p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '',
 title: 'COVID-19',
 itemGuid: 'd88c399d-ac91-44cd-a31a-0e71b2f9c3c3'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{00196F54-F03A-4008-A864-5917B5FD9C0F}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Mycoplasmas</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{8981B5F0-A87B-4A23-BC00-061E993BDEFD}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Overview of Enterovirus Infections</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="8ffb45bc-f1e7-48b3-b6b0-f9336b6e2121_mobile" usemap="#8ffb45bc-f1e7-48b3-b6b0-f9336b6e2121_mobile" width="326" height="90">
 <map name="8ffb45bc-f1e7-48b3-b6b0-f9336b6e2121_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="8ffb45bc-f1e7-48b3-b6b0-f9336b6e2121_tablet" usemap="#8ffb45bc-f1e7-48b3-b6b0-f9336b6e2121_tablet" width="326" height="90">
 <map name="8ffb45bc-f1e7-48b3-b6b0-f9336b6e2121_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="8ffb45bc-f1e7-48b3-b6b0-f9336b6e2121_desktop" usemap="#8ffb45bc-f1e7-48b3-b6b0-f9336b6e2121_desktop" width="326" height="90">
 <map name="8ffb45bc-f1e7-48b3-b6b0-f9336b6e2121_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd03
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="D88C399DAC9144CDA31A0E71B2F9C3C3">
<div id="hiddentblcontents" style="display:none"></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>